LHC Group Inc. (NASDAQ:LHCG) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.
According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “
Several other research analysts have also issued reports on the company. Stephens started coverage on LHC Group in a research report on Friday, June 17th. They set an “overweight” rating and a $55.00 target price for the company. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $46.00 target price (down from $50.00) on shares of LHC Group in a research report on Tuesday, September 13th. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $47.71.
Shares of LHC Group (NASDAQ:LHCG) opened at 37.16 on Wednesday. LHC Group has a 52 week low of $32.77 and a 52 week high of $49.34. The company’s 50 day moving average price is $36.63 and its 200-day moving average price is $39.99. The firm has a market capitalization of $674.57 million, a PE ratio of 19.46 and a beta of 0.64.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported $0.52 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.52. LHC Group had a return on equity of 9.64% and a net margin of 3.87%. The company earned $226 million during the quarter, compared to analysts’ expectations of $221.09 million. During the same period in the prior year, the company earned $0.51 EPS. LHC Group’s revenue was up 12.9% compared to the same quarter last year. On average, equities research analysts expect that LHC Group will post $1.99 EPS for the current fiscal year.
In other LHC Group news, Director Kenneth E. Thorpe sold 1,450 shares of the stock in a transaction dated Monday, August 22nd. The stock was sold at an average price of $36.88, for a total transaction of $53,476.00. Following the completion of the sale, the director now directly owns 17,550 shares in the company, valued at approximately $647,244. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 18.30% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Rothschild Asset Management Inc. increased its stake in shares of LHC Group by 26.6% in the second quarter. Rothschild Asset Management Inc. now owns 371,297 shares of the company’s stock valued at $16,070,000 after buying an additional 77,994 shares in the last quarter. BlackRock Fund Advisors increased its stake in shares of LHC Group by 8.5% in the second quarter. BlackRock Fund Advisors now owns 980,256 shares of the company’s stock valued at $42,425,000 after buying an additional 76,859 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of LHC Group by 4.1% in the second quarter. Vanguard Group Inc. now owns 1,445,895 shares of the company’s stock valued at $62,578,000 after buying an additional 57,246 shares in the last quarter. First Light Asset Management LLC increased its stake in shares of LHC Group by 31.5% in the second quarter. First Light Asset Management LLC now owns 226,943 shares of the company’s stock valued at $9,822,000 after buying an additional 54,406 shares in the last quarter. Finally, FMR LLC increased its stake in shares of LHC Group by 3.3% in the second quarter. FMR LLC now owns 1,620,050 shares of the company’s stock valued at $70,116,000 after buying an additional 51,152 shares in the last quarter. Hedge funds and other institutional investors own 80.71% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.